Published online before print February 16, 2004, doi: 10.1161/01.HYP.0000118584.33350.7d
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;43:739.)
© 2004 American Heart Association, Inc.
Scientific Contributions |
Hypertensive Myocardial Fibrosis and Diastolic Dysfunction
Another Model of Inflammation?
From Internal Medicine III and Cardiovascular Research Institute (F.K., H.K., K.T., T.I.), Kurume University School of Medicine, Kurume; Pathology II (M.T.), Kumamoto University School of Medicine, Kumamoto; and Cardiovascular Medicine (A.T., K.E.), Graduate School of Medical Science, Kyushu University, Fukuoka, Japan.
Correspondence to Dr Hisashi Kai, Internal Medicine III and Cardiovascular Research Institute, Kurume University School of Medicine, 67 Asahimachi, Kurume 830-0011, Japan. E-mail naikai{at}med.kurume-u.ac.jp
Excessive myocardial fibrosis deteriorates diastolic function in hypertensive hearts. Involvement of macrophages is suggested in fibrotic process in various diseased situations. We sought to examine the role of macrophages in myocardial remodeling and cardiac dysfunction in pressure-overloaded hearts. In Wistar rats with suprarenal aortic constriction, pressure overload induced perivascular macrophage accumulation and fibroblast proliferation with a peak at day 3, decreasing to lower levels by day 28. Myocyte chemoattractant protein (MCP)-1 mRNA was upregulated after day 1, peaking at day 3 and returning to insignificant levels by day 28, whereas transforming growth factor (TGF)-ß induction was observed after day 3, with a peak at day 7, and remained relatively elevated at day 28. After day 7, concentric left ventricular (LV) hypertrophy developed, associated with reactive fibrosis and myocyte hypertrophy. At day 28, echocardiography showed normal LV fractional shortening but decreased ratio of early to late filling wave of transmitral Doppler velocity, and hemodynamic studies revealed elevated LV end-diastolic pressure, suggesting normal systolic but impaired diastolic function. Chronic treatment with an anti-MCP-1 monoclonal neutralizing antibody inhibited not only macrophage accumulation but also fibroblast proliferation and TGF-ß induction. Furthermore, the neutralizing antibody attenuated myocardial fibrosis, but not myocyte hypertrophy, and ameliorated diastolic dysfunction without affecting blood pressure and systolic function. In conclusion, roles of MCP-1-mediated macrophage accumulation are suggested in myocardial fibrosis in pressure-overloaded hearts through TGF-ß-mediated process. Inhibition of inflammation may be a new strategy to prevent myocardial fibrosis and resultant diastolic dysfunction in hypertensive hearts.
Key Words: macrophages • fibrosis • hypertension • diastole
This article has been cited by other articles:
 |
|
 |
|
  J. Lin, X. Zhu, A. R. Chade, K. L. Jordan, R. Lavi, E. Daghini, M. E. Gibson, A. Guglielmotti, A. Lerman, and L. O. Lerman Monocyte Chemoattractant Proteins Mediate Myocardial Microvascular Dysfunction in Swine Renovascular Hypertension Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1810 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kudo, H. Kai, H. Kajimoto, M. Koga, N. Takayama, T. Mori, A. Ikeda, S. Yasuoka, T. Anegawa, H. Mifune, et al. Exaggerated Blood Pressure Variability Superimposed on Hypertension Aggravates Cardiac Remodeling in Rats via Angiotensin II System-Mediated Chronic Inflammation Hypertension, October 1, 2009; 54(4): 832 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kayama, T. Minamino, H. Toko, M. Sakamoto, I. Shimizu, H. Takahashi, S. Okada, K. Tateno, J. Moriya, M. Yokoyama, et al. Cardiac 12/15 lipoxygenase-induced inflammation is involved in heart failure J. Exp. Med., July 6, 2009; 206(7): 1565 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Levick, J. L. McLarty, D. B. Murray, R. M. Freeman, W. E. Carver, and G. L. Brower Cardiac Mast Cells Mediate Left Ventricular Fibrosis in the Hypertensive Rat Heart Hypertension, June 1, 2009; 53(6): 1041 - 1047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Heymans, E. Hirsch, S. D. Anker, P. Aukrust, J.-L. Balligand, J. W. Cohen-Tervaert, H. Drexler, G. Filippatos, S. B. Felix, L. Gullestad, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail, February 1, 2009; 11(2): 119 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Copaja Soto, R. Valenzuela, A. Saldana, M. Paz Ocaranza, J. E. Jalil, C. Vio, P. Lijnen, G. E. Ordenes, R. Vivar Sanchez, S. Lavandero, et al. Early expression of monocyte chemoattractant protein-1 correlates with the onset of isoproterenol-induced cardiac fibrosis in rats with distinct angiotensin-converting enzyme polymorphism Journal of Renin-Angiotensin-Aldosterone System, September 1, 2008; 9(3): 154 - 162. [Abstract] [PDF]
|
|
|
|
 |
|
 Y.-Y. Liu, W.-F. Cai, H.-Z. Yang, B. Cui, Z.-R. Chen, H.-Z. Liu, J. Yan, W. Jin, H.-M. Yan, B.-M. Xin, et al. Bacillus Calmette-Guerin and TLR4 Agonist Prevent Cardiovascular Hypertrophy and Fibrosis by Regulating Immune Microenvironment J. Immunol., June 1, 2008; 180(11): 7349 - 7357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Phrommintikul, L. Tran, A. Kompa, B. Wang, A. Adrahtas, D. Cantwell, D. J. Kelly, and H. Krum Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1804 - H1814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Letavernier, J. Perez, A. Bellocq, L. Mesnard, A. de Castro Keller, J.-P. Haymann, and L. Baud Targeting the Calpain/Calpastatin System as a New Strategy to Prevent Cardiovascular Remodeling in Angiotensin II-Induced Hypertension Circ. Res., March 28, 2008; 102(6): 720 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chen, J. Zhang, T. X. Gan, Y. Chen-Izu, J. D. Hasday, M. Karmazyn, C. W. Balke, and S. M. Scharf Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia J Appl Physiol, January 1, 2008; 104(1): 218 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Mehta, J. E. Rame, A. Khera, S. A. Murphy, R. M. Canham, R. M. Peshock, J. A. de Lemos, and M. H. Drazner Left Ventricular Hypertrophy, Subclinical Atherosclerosis, and Inflammation Hypertension, June 1, 2007; 49(6): 1385 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-Y. Zhu, E. Daghini, A. R. Chade, C. Napoli, E. L. Ritman, A. Lerman, and L. O. Lerman Simvastatin Prevents Coronary Microvascular Remodeling in Renovascular Hypertensive Pigs J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1209 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. d. l. Fuentes, A. L. Brown, S. J. Mathews, A. D. Waggoner, P. F. Soto, R. J. Gropler, and V. G. Davila-Roman Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass Eur. Heart J., March 1, 2007; 28(5): 553 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Levick, D. C. Loch, S. M. Taylor, and J. S. Janicki Arachidonic Acid Metabolism as a Potential Mediator of Cardiac Fibrosis Associated with Inflammation J. Immunol., January 15, 2007; 178(2): 641 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Y. Zhu, E. Daghini, A. R. Chade, M. Rodriguez-Porcel, C. Napoli, A. Lerman, and L. O. Lerman Role of Oxidative Stress in Remodeling of the Myocardial Microcirculation in Hypertension Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1746 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yu, K. Horak, and D. F. Larson Role of T Lymphocytes in Hypertension-Induced Cardiac Extracellular Matrix Remodeling Hypertension, July 1, 2006; 48(1): 98 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Levick, D. Loch, B. Rolfe, R. C. Reid, D. P. Fairlie, S. M. Taylor, and L. Brown Antifibrotic Activity of an Inhibitor of Group IIA Secretory Phospholipase A2 in Young Spontaneously Hypertensive Rats. J. Immunol., June 1, 2006; 176(11): 7000 - 7007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Zieman, V. Melenovsky, and D. A. Kass Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 932 - 943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Heymans, F. Lupu, S. Terclavers, B. Vanwetswinkel, J.-M. Herbert, A. Baker, D. Collen, P. Carmeliet, and L. Moons Loss or Inhibition of uPA or MMP-9 Attenuates LV Remodeling and Dysfunction after Acute Pressure Overload in Mice Am. J. Pathol., January 1, 2005; 166(1): 15 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. T. Weber From Inflammation to Fibrosis: A Stiff Stretch of Highway Hypertension, April 1, 2004; 43(4): 716 - 719. [Full Text] [PDF]
|
|